DexCom: Delivering Consistent Growth

Group 1 - The article highlights DexCom, Inc. (NASDAQ: DXCM) as a focus for investment, particularly noting a temporary stock boost of 10% in late June due to an announcement from the Department of Health and Human Services [1] - The Biotech Forum, led by Bret, offers a model portfolio featuring 12-20 high upside biotech stocks, along with live chat discussions and weekly research updates [1] - The forum emphasizes covered call opportunities in the biotech sector, indicating a trend among seasoned investors [1]